Previous close | 57.50 |
Open | 57.27 |
Bid | 56.55 x 100 |
Ask | 56.99 x 100 |
Day's range | 56.62 - 57.69 |
52-week range | 48.20 - 70.81 |
Volume | |
Avg. volume | 350,488 |
Market cap | 1.194B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 47.72 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Alimera Sciences (ALIM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers. In this article, we are going to take a look at where ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) stands against the other cheap pharmaceutical stocks. The pharmaceutical industry is one of the most interesting sectors to invest in. This is because […]